Literature DB >> 20618333

Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis.

Marie Robin, Hélène Espérou, Régis Peffault de Latour, Anna D Petropoulou, Aliénor Xhaard, Patricia Ribaud, Gérard Socié.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20618333     DOI： 10.1111/j.1365-2141.2010.08276.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.

Authors:  Karen K Ballen; Ann E Woolfrey; Xiaochun Zhu; Kwang Woo Ahn; Baldeep Wirk; Mukta Arora; Biju George; Bipin N Savani; Brian Bolwell; David L Porter; Ed Copelan; Gregory Hale; Harry C Schouten; Ian Lewis; Jean Yves Cahn; Joerg Halter; Jorge Cortes; Matt E Kalaycio; Joseph Antin; Mahmoud D Aljurf; Matthew H Carabasi; Mehdi Hamadani; Philip McCarthy; Steven Pavletic; Vikas Gupta; H Joachim Deeg; Richard T Maziarz; Mary M Horowitz; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2012-03-24       Impact factor: 5.742

2.  Splenectomy as a measure to treat prolonged post-transplant cytopenia associated with hypersplenism.

Authors:  D L Brauer; A P Rapoport; S Yanovich; G Akpek
Journal:  Bone Marrow Transplant       Date:  2014-01-20       Impact factor: 5.483

Review 3.  Allogeneic hematopoietic cell transplantation for myelofibrosis in the era of JAK inhibitors.

Authors:  Vikas Gupta; Parameswaran Hari; Ronald Hoffman
Journal:  Blood       Date:  2012-06-14       Impact factor: 22.113

Review 4.  Allogeneic stem cell transplant for myelofibrosis patients over age 60: likely impact of the JAK2 inhibitors.

Authors:  V Fauble; J Leis; R A Mesa
Journal:  Leuk Suppl       Date:  2012-05-09

Review 5.  Myelofibrosis: to transplant or not to transplant?

Authors:  Rebecca Devlin; Vikas Gupta
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 6.  Allogeneic haematopoietic cell transplantation for myelofibrosis: proposed definitions and management strategies for graft failure, poor graft function and relapse: best practice recommendations of the EBMT Chronic Malignancies Working Party.

Authors:  Donal P McLornan; Juan Carlos Hernandez Boluda; Tomasz Czerw; Nicholas Cross; H Joachim Deeg; Marcus Ditschkowski; Mufaddal T Moonim; Nicola Polverelli; Marie Robin; Mahmoud Aljurf; Eibhlin Conneally; Patrick Hayden; Ibrahim Yakoub-Agha
Journal:  Leukemia       Date:  2021-05-26       Impact factor: 11.528

7.  Effects of spleen status on early outcomes after hematopoietic cell transplantation.

Authors:  G Akpek; M C Pasquini; B Logan; M-A Agovi; H M Lazarus; D I Marks; M Bornhaeüser; O Ringdén; R T Maziarz; V Gupta; U Popat; D Maharaj; B J Bolwell; J D Rizzo; K K Ballen; K R Cooke; P L McCarthy; V T Ho
Journal:  Bone Marrow Transplant       Date:  2012-12-10       Impact factor: 5.483

Review 8.  Current Challenges in Stem Cell Transplantation in Myelofibrosis.

Authors:  Nicolaus Kröger
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

9.  How to manage the transplant question in myelofibrosis.

Authors:  K Ballen
Journal:  Blood Cancer J       Date:  2012-03-02       Impact factor: 11.037
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.